Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/27/1994 | CA2159813A1 A human t-cell receptor of the g-protein coupled receptor family |
10/27/1994 | CA2137833A1 Amino-sugars and glycoproteins, and methods for their preparation; pharmaceutical preparations containing these amino-sugars or glycoproteins, and the uses of these pharmaceuticalpreparations |
10/27/1994 | CA2137785A1 Immunoassay and test kit for thrombin-antithrombin iii complex |
10/26/1994 | EP0621480A2 Diagnosis and monitoring of lung cancer patients by measurement of NCA 50/90 in blood |
10/26/1994 | EP0621341A2 Monoclonal antibodies to bovine cytokines |
10/26/1994 | EP0621340A1 Product and process for the production and purification of recombinant polypeptides |
10/26/1994 | EP0621338A2 Immunosuppressant able to block the interleukin - 2 response |
10/26/1994 | EP0621337A1 Codon optimized DNA sequence for insect toxin AaIT |
10/26/1994 | EP0620860A1 Preparation of recombinant borrelia proteins |
10/26/1994 | EP0620854A1 Expression and purification of recombinant soluble tissue factor |
10/26/1994 | EP0620852A1 Cyclic di-guanylate metabolic enzymes |
10/26/1994 | EP0620851A1 Neuroblastoma-associated regulator gene. |
10/26/1994 | EP0620850A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
10/26/1994 | EP0620739A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
10/26/1994 | EP0566645B1 Method for production of a vegetable protein hydrolyzate |
10/26/1994 | EP0431042B1 A method of preparing an active human neutrophil chemotactic factor polypeptide |
10/26/1994 | EP0174366B1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
10/26/1994 | CN1094093A Progenitor B cell stinulating factor |
10/26/1994 | CN1094092A Chimeric human interferon-gamma-receptor/immunoglobulin polypeptides |
10/26/1994 | CN1094061A Simultaneous determination of HbALc and haemoglobin variants with a glycation analogeous to HbALc |
10/25/1994 | US5359135 Detection in soil, water, air by preferential affinity to monoclonal antibodies |
10/25/1994 | US5359051 Compounds useful in the synthesis of nucleic acids capable of cleaning RNA |
10/25/1994 | US5359047 Nucleic acids encoding DNA structure-specific recognition protein and uses therefor |
10/25/1994 | US5359045 DNA sequence encoding a polypeptide including nucleic acid encoding amino acids 361-404 and 951-1002 |
10/25/1994 | US5359036 Growth hormone-like glycoproteins |
10/25/1994 | US5359034 Cysteine depleted IL-6 muteins |
10/25/1994 | US5359033 Cleaved dimers of mullerian inhibiting substance-like polypeptides |
10/25/1994 | US5358870 Emulsification of petroleum oils and aqueous bacterial enzyme, then incubation, for selective cleavage of carbon-sulfur bonds |
10/25/1994 | US5358869 Desulfurization of coal and oils with Rhodococcus and Bacillus by aerobic metabolism |
10/25/1994 | US5358867 DNA cloning and expression of an L7 protein which modulates the 2'-5' oligosynthetase and H2-K*K response to type-I interferon |
10/25/1994 | US5358851 Polyclonal antibody from immunizing an animal with immunogenic carrier protein conjugated to p-tolylacetic acid, then binding product to the aromatic ring of benzene or naphthalene derivatives for detection |
10/25/1994 | US5358849 Hybridomas; culture products; radioisotope labelling; cancer screening |
10/25/1994 | US5358707 Oxidized variants of GM-CSF |
10/25/1994 | US5358649 Diagnosis for porcine malignant hyperthermia |
10/23/1994 | CA2121096A1 Monoclonal antibodies to bovine cytokines |
10/21/1994 | CA2116261A1 Epitopic regions of pneumococcal surface protein a |
10/19/1994 | EP0620276A1 Humanised antibodies |
10/19/1994 | EP0620275A1 A bovine group I phospholipase A2 receptor |
10/19/1994 | EP0619843A1 Icams immunoglobulin constant region soluble fusion proteins |
10/19/1994 | EP0619842A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors |
10/19/1994 | EP0619841A1 T-cadherin adhesion molecule |
10/19/1994 | EP0619839A1 Novel polypeptides for promoting cell attachment |
10/19/1994 | EP0619836A1 Methods for production of purified soluble type b and type a human platelet-derived growth factor receptor fragments |
10/19/1994 | EP0619824A1 Trophoblast interferons and their use |
10/19/1994 | EP0619742A1 Transfection of lung via aerosolized transgene delivery |
10/19/1994 | EP0619738A1 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
10/19/1994 | EP0506780B1 Stable integration of dna in bacterial genomes |
10/19/1994 | CN1093751A Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof |
10/19/1994 | CN1093598A Use of Il-10 to preventor treat insulin-dependent diabetes mellitus |
10/18/1994 | US5356877 Methods for promoting growth using porcine growth hormone analogs |
10/18/1994 | US5356875 Anti-thrombin polypeptides and pharmaceutical compositions thereof |
10/18/1994 | US5356805 Culture product of the microorganism myrothecium |
10/18/1994 | US5356798 Adding egg yolk free of lipoproteins and lipids to increase expression of proteins |
10/18/1994 | US5356794 Purified enzymatic preparation derived from chromobacterium violaceum, method for preparing it and its use in the production of α, β-dehydrotryptophanyl-peptides |
10/18/1994 | US5356772 Process for preparing an improved western blot immunoassay |
10/18/1994 | US5356637 Method for preparing an enzymatic hydrolysate |
10/18/1994 | US5356622 Homogenizing and sonicating flea midgut, separating and recovering |
10/18/1994 | CA1332650C Polysaccharides and antiviral drugs containing the same as active ingredient |
10/17/1994 | CA2121302A1 Amphotropic virus receptor |
10/13/1994 | WO1994023058A1 Suppressor of hiv replication and transcription |
10/13/1994 | WO1994023040A1 Methods and dna expression systems for over-expression of proteins in host cells |
10/13/1994 | WO1994023037A1 Pharmaceuticals based on papillomaviruses |
10/13/1994 | WO1994023035A2 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN Phl p II |
10/13/1994 | WO1994023034A2 Variant insulin-like growth factor i receptor subunits and methods for use thereof |
10/13/1994 | WO1994023033A1 Human osteoclast-specific and -related genes |
10/13/1994 | WO1994023032A1 Therapeutic uses of keratinocyte growth factor |
10/13/1994 | WO1994023031A1 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
10/13/1994 | WO1994023030A2 Methods and materials relating to the functional domains of dna binding proteins |
10/13/1994 | WO1994023025A1 Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor |
10/13/1994 | WO1994023015A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/13/1994 | WO1994022918A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/13/1994 | WO1994022916A1 Biologically active polypeptide fusion dimers |
10/13/1994 | WO1994022914A1 Chimeric cytokine receptors in lymphocytes |
10/13/1994 | WO1994022478A1 PREVENTION OF TUMORS WITH MONOCLONAL ANTIBODIES AGAINST $i(NEU) |
10/13/1994 | WO1994022475A1 Cloned leptospira outer membrane protein |
10/13/1994 | WO1994022474A1 Method for treating kawasaki syndrome via immune modulation |
10/13/1994 | WO1994022466A1 Methods of using insulin-like growth factor binding proteins |
10/13/1994 | WO1994022464A1 Urokinase plasminogen activator fragments |
10/13/1994 | WO1994020621A3 Proteinaceous particles containing retroviral element |
10/13/1994 | WO1994020620A3 Cloning of the zymocin gene and use of zymocin in beverages |
10/13/1994 | WO1994018227A3 Improved method for the refolding of proteins |
10/13/1994 | WO1994017828A3 Treatment for insulin dependent diabetes |
10/13/1994 | WO1994017189A3 Protein kinases |
10/13/1994 | WO1994012635A3 Novel seven transmembrane receptors |
10/13/1994 | WO1994012630A3 Method for producing polypeptide via bacterial fermentation |
10/13/1994 | CA2160154A1 Methods of using insulin-like growth factor binding proteins |
10/13/1994 | CA2160011A1 Chimeric cytokine receptors in lymphocytes |
10/13/1994 | CA2159637A1 Urokinase plasminogen activator fragments |
10/13/1994 | CA2159595A1 Suppressor of hiv replication and transcription |
10/13/1994 | CA2159499A1 Biologically active polypeptide fusion dimers |
10/13/1994 | CA2159080A1 Human osteoclast-specific and -related genes |
10/13/1994 | CA2158554A1 Pharmaceuticals based on papillomaviruses |
10/13/1994 | CA2158540A1 Cloned leptospira outer membrane protein |
10/13/1994 | CA2158056A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof |
10/13/1994 | CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii |
10/13/1994 | CA2135912A1 A retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and uses of said vector |
10/12/1994 | EP0619372A1 Tumor necrosis factor muteins |
10/12/1994 | EP0619371A1 Polypeptide derived from a glioblastoma cell line, its use and DNAs encoding it |
10/12/1994 | EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body |